Homeopathy for COVID-19 Prevention: Report of an Intervention at a Brazilian Service Sector Company.
Homeopathy
; 111(2): 105-112, 2022 05.
Article
in English
| MEDLINE | ID: covidwho-1475536
ABSTRACT
BACKGROUND:
COVID-19 quickly became a serious public health problem worldwide, with serious economic and social repercussions. Homeopaths around the world have been studying to find a genus epidemicus (GE) medicine that might help in the prevention and treatment of this disease.OBJECTIVE:
To compare the incidence of COVID-19 between employees who received or did not receive a homeopathic GE medicine for disease prevention.METHODS:
Retrospective cohort analysis. The study population comprised all employees of a service sector company in São Paulo, Brazil, and followed up by the corporate Occupational Health department. Intervention consisted of administering Arsenicum album 30cH in a one-weekly dose. Primary outcome was incidence of COVID-19 during 3-months' follow-up (April to July, 2020).RESULTS:
We analyzed 1,642 of 1,703 employees without previous diagnosis of COVID-19 at onset of the study period 53.34% of employees were referred to telework at home and did not receive intervention (Group 1, G1); 24.66% remained working on-premises in the state of São Paulo and received the intervention (Group 2, G2); 21.98% remained working on company premises in other states and did not receive intervention (Group 3, G3). Incidence rate of COVID-19 was respectively 13.35%, 0.74%, and 67.87% (p < 0.001). The odds ratio of being infected in (1) G3 versus G1 was 13.70 (95% confidence interval [CI], 10.21 to 18.39), (2) G3 versus G2 was 283.02 (95% CI, 88.98 to 900.18), and (3) G1 versus G2 was 20.66 (95% CI, 6.53 to 65.39).LIMITATIONS:
The present is a retrospective analysis of a real-world experience. We could not ensure direct observed treatment, and neither could we control adherence to general prevention measures outside company premises.CONCLUSION:
The incidence of COVID-19 was significantly lower amongst on-premises employees who received the GE medication in comparison to workers who did not receive the intervention (those either at other company premises or teleworking at home).
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Materia Medica
/
COVID-19
/
Homeopathy
Type of study:
Cohort study
/
Experimental Studies
/
Observational study
/
Prognostic study
Topics:
Vaccines
Limits:
Humans
Country/Region as subject:
South America
/
Brazil
Language:
English
Journal:
Homeopathy
Journal subject:
Complementary Therapies
Year:
2022
Document Type:
Article
Affiliation country:
S-0041-1733972
Similar
MEDLINE
...
LILACS
LIS